Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN).

Circulation journal : official journal of the Japanese Circulation Society(2023)

引用 1|浏览50
暂无评分
摘要
This pilot study showed the safety and feasibility of prasugrel monotherapy in selected low-risk Japanese patients with CCS. This "aspirin-free" strategy may be a safe alternative to traditional DAPT following PCI.
更多
查看译文
关键词
Antiplatelet monotherapy,Coronary artery disease,Drug-eluting stent,Percutaneous coronary intervention,Prasugrel
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要